Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innospec (IOSP) Capital Expenditures (2016 - 2025)

Innospec's Capital Expenditures history spans 16 years, with the latest figure at $14.6 million for Q4 2025.

  • For Q4 2025, Capital Expenditures rose 273.81% year-over-year to $14.6 million; the TTM value through Dec 2025 reached $50.3 million, up 140.67%, while the annual FY2025 figure was $50.3 million, 140.67% up from the prior year.
  • Capital Expenditures for Q4 2025 was $14.6 million at Innospec, up from $14.3 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $21.2 million in Q3 2024 and bottomed at -$27.4 million in Q4 2021.
  • The 5-year median for Capital Expenditures is $7.6 million (2021), against an average of $4.4 million.
  • The largest annual shift saw Capital Expenditures tumbled 442.5% in 2021 before it skyrocketed 646.15% in 2025.
  • A 5-year view of Capital Expenditures shows it stood at -$27.4 million in 2021, then surged by 109.85% to $2.7 million in 2022, then skyrocketed by 59.26% to $4.3 million in 2023, then crashed by 295.35% to -$8.4 million in 2024, then surged by 273.81% to $14.6 million in 2025.
  • Per Business Quant, the three most recent readings for IOSP's Capital Expenditures are $14.6 million (Q4 2025), $14.3 million (Q3 2025), and $14.2 million (Q2 2025).